Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Biodentine Rejuvenates Aged Dental Pulp Stem Cells via Wnt/β

    2026-04-20

    Biodentine Rejuvenates Human Dental Pulp Stem Cells Through Wnt/β-Catenin Pathway

    Study Background and Research Question

    Vital pulp therapy (VPT) aims to preserve the function of dental pulp and maintain tooth integrity, especially relevant in geriatric dentistry. However, the success of VPT is limited by the decreased proliferative and differentiation capacity of human dental pulp stem cells (hDPSCs) with age. Traditional pulp capping materials, such as mineral trioxide aggregate (MTA), present drawbacks including tooth discoloration and poor handling properties. Biodentine, a newer bioceramic material, has shown promise in overcoming these limitations. The key research question addressed by Zhang et al. (2025) is whether Biodentine can counteract the aging process in hDPSCs and, if so, through which molecular mechanisms (paper).

    Key Innovation from the Reference Study

    This study provides direct evidence that Biodentine not only promotes the proliferation of hDPSCs but also exerts a marked anti-aging effect, especially in cells derived from older donors. Crucially, the authors establish that these rejuvenating effects are mediated via activation of the Wnt/β-catenin signaling pathway. The use of a specific pathway inhibitor, XAV939, allowed the team to dissect the mechanistic link, highlighting Biodentine's targeted molecular influence (paper).

    Methods and Experimental Design Insights

    The investigators isolated hDPSCs from two donor age groups (18–27 and 60–70 years) to model age-related decline in stem cell function. Cells were characterized for mesenchymal stem cell markers and subjected to proliferation and senescence assays. Biodentine extract was prepared and applied to cultures at varying concentrations to determine the optimal proliferative dose using CCK-8 viability assays. To probe mechanism, the Wnt/β-catenin pathway was inhibited using XAV939. Key endpoints included:
    • Cell cycle analysis (S-phase proportion)
    • qRT-PCR of odonto/osteogenic differentiation markers
    • Senescence-associated β-galactosidase staining
    • Western blot for Wnt/β-catenin pathway and senescence markers
    The optimal Biodentine concentration for promoting hDPSC proliferation was identified as 0.2 mg/mL (source: paper).

    Protocol Parameters

    • Proliferation assay (CCK-8) | 0.2 mg/mL Biodentine extract | hDPSC proliferation | Determined as optimal for maximal proliferation | paper
    • Senescence assay (β-gal staining) | 48 h exposure | Aged hDPSC models | Quantifies anti-aging effect | paper
    • Wnt/β-catenin inhibition | 10 μM XAV939 | Mechanistic validation | Confirms pathway dependence | paper
    • Growth factor supplement (e.g., bovine insulin) | 5–10 μg/mL (typical for MSCs) | Enhances cell proliferation and viability | Supports robust cell expansion in analogous protocols | workflow_recommendation

    Core Findings and Why They Matter

    The study found that hDPSCs from older donors exhibited a significant reduction in S-phase cell population and increased senescence marker expression compared to younger counterparts. Application of Biodentine extract at 0.2 mg/mL resulted in:
    • Enhanced proliferation of both young and aged hDPSCs
    • Upregulation of odonto/osteogenic genes (e.g., DSPP, RUNX2)
    • Marked reduction in senescence-associated β-galactosidase activity
    • Activation of Wnt/β-catenin signaling, as evidenced by increased β-catenin protein levels
    Inhibiting Wnt/β-catenin pathway with XAV939 abolished the anti-aging and proliferative effects of Biodentine, confirming pathway specificity. These results directly link Biodentine's action to cellular rejuvenation mechanisms, suggesting it can restore regenerative potential in aged dental tissues (paper).

    Comparison with Existing Internal Articles

    Several internal resources have explored the use of peptide hormones, particularly bovine insulin, as growth factor supplements for cultured cells. For example, the article "Bovine Insulin: High-Purity Peptide Hormone for Cell Culture" highlights the importance of insulin from bovine pancreas in supporting robust cell proliferation and glucose metabolism regulation, which are foundational for advanced stem cell and regenerative research (internal_article). While the mechanisms differ—insulin primarily acts via metabolic and PI3K/Akt pathways, whereas Biodentine targets Wnt/β-catenin—the unifying theme is the enhancement of cell viability and expansion capacity in vitro. Similarly, "Bovine Insulin: Optimizing Cell Proliferation and Metabol..." discusses the role of high-purity bovine insulin as a cell proliferation enhancer, emphasizing its reproducibility and biochemical reliability in cell culture workflows (internal_article). These strategies are complementary: while Biodentine rejuvenates stem cells via anti-senescence pathways, insulin supplements optimize the baseline proliferative environment. Integrating both approaches could further enhance regenerative protocols, especially in contexts where cellular aging is a limiting factor.

    Limitations and Transferability

    The findings by Zhang et al. are compelling but several limitations merit consideration:
    • The study was performed in vitro; in vivo efficacy and long-term regenerative outcomes remain to be validated (paper).
    • Donor heterogeneity and the influence of systemic factors (e.g., diabetes, inflammation) were not addressed.
    • The optimal concentration of Biodentine was specific to hDPSC cultures and may require adjustment for other stem cell types or clinical scenarios.
    • Transferability to non-dental tissues or broader stem cell aging contexts is currently speculative, with no direct evidence yet.

    Research Support Resources

    For laboratories seeking to replicate or extend these findings, it is essential to use validated, high-purity supplements and reagents. Bovine Insulin (SKU A5981) from APExBIO is a double-chain peptide hormone derived from bovine pancreas, widely employed as a growth factor supplement for cultured cells to promote cell proliferation and metabolism (workflow_recommendation). Its established use in supporting cell expansion and viability can complement protocols focused on stem cell rejuvenation and anti-aging interventions. Researchers should note that bovine insulin is soluble at concentrations ≥10.26 mg/mL in DMSO with ultrasonic assistance and is best used promptly after preparation (source: product_spec).